Who owns Imunon, Inc.? Owners, funding and legal record

Before you sign or pay

• Court and bankruptcy: No federal court case or bankruptcy filing found under Imunon, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
• Leadership changes: the latest reported is Jeffrey Church, Chief Financial Officer (Form 8-K filed 2026-06-30). Check you are dealing with the people now in charge.
• Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Armistice Capital, LLC (filed 2026-08-14).

Who is behind it

Imunon, Inc.: incorporated in Delaware; business address in Lawrenceville, New Jersey; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-14).

Officers and directors, each with the role and the filing that names them:

• Stacy R. Lindborg: Executive Officer, Director (Form D, 2025-05-28)
• Michael H. Tardugno: Executive Officer, Director (Form D, 2025-05-28)
• David Gaiero: Executive Officer (Form D, 2025-05-28)
• Susan Eylward: Executive Officer (Form D, 2025-05-28)
• Douglas Faller: Executive Officer (Form D, 2025-05-28)
• Khursheed Anwer: Executive Officer (Form D, 2025-05-28)
• Donald P. Braun: Director (Form D, 2025-05-28)
• James E. Dentzer: Director (Form D, 2025-05-28)
• Frederick J. Fritz: Director (Form D, 2025-05-28)
• Christine Pellizzari: Director (Form D, 2025-05-28)

Money raised

Latest IPO step: Imunon, Inc. filed to go public (S-1, 2025-05-30).

IPO filings: S-1, 2025-05-30, RW, 2025-05-22, S-1/A, 2025-05-19, S-1/A, 2025-05-13, S-1, 2025-04-04; ticker IMNN on Nasdaq.

Related pages

Leadership changes5%+ holders

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

All companies

Not for employment, credit, insurance or tenancy decisions.